Stay Up to Date With All Things Aurion Biotech
Learn more about how we’re making progress in our mission to bring transformational regenerative therapies to patients in need.
Press releases
Filter by year
-
Aurion Biotech Announces Positive Topline Data for Phase 1/2 Clinical Trial of AURN001, an Allogeneic Cell Therapy Product Candidate for the Treatment of Corneal Edema Secondary to Corneal Endothelial Dysfunction
Read More -
Aurion Biotech Launches Vyznova® in Japan for the Treatment of Bullous Keratopathy of the Cornea
Read More -
Aurion Biotech to Present at the 42nd Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) and Ophthalmology European Futures Forum
Read More -
Why BTD / RMAT Designations Matter
Read More -
Aurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Its Drug Candidate AURN001
Read More -
Aurion Biotech CEO Greg Kunst Named Ernst & Young 2024 Entrepreneur of the Year Mountain West Region
Read More -
Aurion Biotech Announces Completion of Enrollment In Phase 1 / 2 Clinical Trial
Read More -
Aurion Biotech To Present Clinical Data at the 2024 American Society of Cataract and Refractive Surgery (Ascrs) Annual Meeting
Read More -
Aurion Biotech Announces First Canadian Subject Dosed in Phase 1 / 2 Clinical Trial
Read More
-
Greg Kunst, CEO of Aurion Biotech, Receives Healthcare Leadership Award from Puget Sound Business Journal
Read More -
Aurion Biotech Named “Regenerative Therapeutics Company Of The Year” By BioTech Breakthrough
Read More -
The Importance of Teamwork
Read More -
Aurion Biotech Announces First Subject Dosed in U.S. Phase 1 / 2 Clinical Trial
Read More -
Aurion Biotech Wins Clinical Advance of the Year Award at Biotech Week Boston
Read More -
Aurion Biotech to Present Clinical Trial Results at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
Read More -
March Milestone
Read More -
Aurion Biotech Receives Approval from Japan’s PMDA for New Drug Application
Read More
-
Jonathan Sparks, JD, PhD Joins Aurion Biotech as Chief Legal Officer
Read More -
Aurion Biotech Expands Its Leadership Team
Read More -
Aurion Biotech Wins Prestigious Prix Galien Startup Award
Read More -
Living Our Values at Aurion Biotech
Read More -
A Culture of Curiosity and Collaboration
Read More -
Summer Solstice or Mid-year Madness?
Read More -
Aurion Biotech Appoints Dr. Michael Goldstein as President and Chief Medical Officer
Read More -
Aurion Biotech Wins ASCRS Eyecelerator Award
Read More -
AURION BIOTECH RAISES $120 MILLION FROM DEERFIELD, PETRICHOR, FLYING L PARTNERS, FALCON VISION/KKR AND VISIONARY VENTURES
Read More
-
Greg Kunst Appointed CEO of Aurion Biotech
Read More -
Why I Joined Aurion Biotech
Read More -
Aurion Biotech Wins “Best in Show” at AAO Eyecelerator Conference
Read More -
Aurion Biotech Announces Medical Advisory Board
Read More -
Aurion Biotech Announces Strategic Investments in Manufacturing
Read More -
Aurion Biotech Announces IOTA Cell Therapy Trial
Read More -
Planes, Trains and…Hurricanes?
Read More -
Aurion Biotech Appoints Professor Shigeru Kinoshita, MD, PhD, to Its Medical Advisory Board
Read More -
Aurion Biotech Names Edward Holland, MD, Chair of Medical Advisory Board
Read More -
What Drive Success? A Conversation with Dr. Edward Holland
Read More -
Arnaud Lacoste Joins Aurion Biotech as Chief Scientific Officer
Read More -
When We Reach the End of What We Should Know
Read More
In the news
Filter by year
-
The Ophthalmologist: Innovative Cell Therapies in Ophthalmology
Read More -
WIO: Aurion Cell Therapy: Consistency Across Multiple Clinical Trials
Read More -
BioWorld: Aurion Victorious with Vyznova Cell Therapy Approval in Japan
Read More -
Forbes: Innovation Rx
Read More -
Optometry Times: Cell Therapy for Corneal Endothelial Disease Gains Traction
Read More -
Corneal Physician: What’s New in Eye Banking
Read More -
Ophthalmology Times: Innovations in the Treatment of Corneal Dystrophies
Read More -
Ophthalmology 360: Conversation with Dr. Matt Giegengack
Read More -
Ophthalmology Times: Jumping into Cell Therapy with Collaboration, Innovation
Read More
-
Healio: Aurion Wins Prestigious Prix Galien Award
Read More -
EyeWorld: Aurion Biotech Receives Best in Show
Read More -
The Ophthalmologist: Cracking the Cornea Conundrum
Read More -
BIoSpace: Aurion Raises $120 Million to Advance Cell Therapy Platform
Read More -
Genetic Engineering & Biotechnology News: Aurion Biotech Industrializing Ophthalmologic Cell-Based Therapy
Read More
-
BioSpace: How You React Now Determines Your Next Success
Read More -
Ophthalmology Times: Exploratory Trials in Cell Therapy
Read More -
The New England Journal of Medicine: Injection of Cultured Cells With a ROCK Inhibitor for Bullous Keratopathy
Read More -
AAO Ophthalmology Journal: Five-Year Follow-up…Cultured Corneal Endothelial Cells
Read More -
Corneal Physician: Injectable Corneal Endothelial Cells
Read More -
JAMA Ophthalmology: Global Survey of Corneal Transplantation & Eye Banking
Read More